APA-referens (7:e uppl.)

Bekker, P., Keshav, S., Wei, Z., Ertl, L., Wang, Y., Lai, N., . . . Schall, T. (2007). Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease.

Chicago-referens (17:e uppl.)

Bekker, P., S. Keshav, Z. Wei, L. Ertl, Y. Wang, N. Lai, J. Wright, S. Ungashe, och T. Schall. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.

MLA-referens (9:e uppl.)

Bekker, P., et al. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.